These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 9618028

  • 1. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity.
    Purohit A, Vernon KA, Hummelinck AE, Woo LW, Hejaz HA, Potter BV, Reed MJ.
    J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):269-75. PubMed ID: 9618028
    [Abstract] [Full Text] [Related]

  • 2. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
    Woo LL, Purohit A, Malini B, Reed MJ, Potter BV.
    Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
    [Abstract] [Full Text] [Related]

  • 3. Recent advances in the development of steroid sulphatase inhibitors.
    Purohit A, Hejaz HA, Woo LW, van Strien AE, Potter BV, Reed MJ.
    J Steroid Biochem Mol Biol; 1999 Oct; 69(1-6):227-38. PubMed ID: 10418996
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor.
    Reed JE, Woo LW, Robinson JJ, Leblond B, Leese MP, Purohit A, Reed MJ, Potter BV.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):169-75. PubMed ID: 15047163
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
    Hejaz HA, Purohit A, Mahon MF, Reed MJ, Potter BV.
    J Med Chem; 1999 Aug 12; 42(16):3188-92. PubMed ID: 10447965
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Measurement of oestrone sulphatase activity in white blood cells to monitor in vivo inhibition of steroid sulphatase activity by oestrone-3-O-sulphamate.
    Purohit A, Froome VA, Wang DY, Potter BV, Reed MJ.
    J Steroid Biochem Mol Biol; 1997 May 12; 62(1):45-51. PubMed ID: 9366497
    [Abstract] [Full Text] [Related]

  • 11. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
    Purohit A, Williams GJ, Howarth NM, Potter BV, Reed MJ.
    Biochemistry; 1995 Sep 12; 34(36):11508-14. PubMed ID: 7547880
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
    Woo LW, Howarth NM, Purohit A, Hejaz HA, Reed MJ, Potter BV.
    J Med Chem; 1998 Mar 26; 41(7):1068-83. PubMed ID: 9544207
    [Abstract] [Full Text] [Related]

  • 14. The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells.
    Purohit A, Dauvois S, Parker MG, Potter BV, Williams GJ, Reed MJ.
    J Steroid Biochem Mol Biol; 1994 Jul 26; 50(1-2):101-4. PubMed ID: 8049127
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
    Lawrence Woo LW, Leblond B, Purohit A, Potter BV.
    Bioorg Med Chem; 2012 Apr 15; 20(8):2506-19. PubMed ID: 22455789
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate.
    Raobaikady B, Purohit A, Chander SK, Woo LW, Leese MP, Potter BV, Reed MJ.
    J Steroid Biochem Mol Biol; 2003 Feb 15; 84(2-3):351-8. PubMed ID: 12711022
    [Abstract] [Full Text] [Related]

  • 17. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase.
    Fischer DS, Woo LW, Mahon MF, Purohit A, Reed MJ, Potter BV.
    Bioorg Med Chem; 2003 Apr 17; 11(8):1685-700. PubMed ID: 12659755
    [Abstract] [Full Text] [Related]

  • 18. Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity.
    Fischer DS, Chander SK, Woo LW, Fenton JC, Purohit A, Reed MJ, Potter BV.
    J Steroid Biochem Mol Biol; 2003 Feb 17; 84(2-3):343-9. PubMed ID: 12711021
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of oestrone-3-O-sulphamate.
    Hidalgo Aragones MI, Purohit A, Parish D, Sahm UG, Pouton CW, Potter BV, Reed MJ.
    J Steroid Biochem Mol Biol; 1996 Aug 17; 58(5-6):611-7. PubMed ID: 8918989
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.